SynthesisRenal failure2024

Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis.

Shanshen Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.